Global Tuberculosis Vaccine Treatment Supply, Demand and Key Producers, 2026-2032
The global Tuberculosis Vaccine Treatment market size is expected to reach $ 103 million by 2032, rising at a market growth of 2.8% CAGR during the forecast period (2026-2032).
Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Gu?rin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme. Besides, BCG Vaccine is also used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive.In 2024, global Tuberculosis Vaccine Treatment production reached approximately 318 m units, with an average global market price of around US$ 0.21 perunit
The global TB burden remains high, with WHO reporting over 10 million new cases annually, concentrated mainly in Asia and Africa, providing strong demand for tuberculosis vaccines. Governments are implementing immunization programs and public health policies to increase vaccination coverage and support new vaccine R&D through policy and funding incentives. Annual reports of leading vaccine manufacturers show sustained R&D investment, capacity expansion, and export growth, maintaining steady global market expansion. Brokerage research indicates that the need for multidrug-resistant TB (MDR-TB) prevention and new trackable vaccine management systems will further enhance vaccine penetration in public health and clinical prevention.
Tuberculosis vaccine R&D and manufacturing face challenges such as technical complexity, long clinical trial cycles, and strict regulatory approvals. Annual reports highlight that raw material supply, cold-chain logistics, and storage requirements impose high demands on cost and supply stability. Vaccination coverage in some regions is limited by insufficient public health resources, patient adherence, and vaccine accessibility, while policy adjustments, price controls, and reimbursement coverage changes may affect market revenue. Differing international regulations and approval requirements increase uncertainties for overseas market expansion.
Downstream demand is extending toward full-population and lifecycle vaccination and immunization management. Newborns and children remain the core target population, while high-risk adult protection needs are growing. Digital vaccine management and remote monitoring platforms facilitate end-to-end tracking of vaccine administration, improving adherence and efficacy evaluation. Brokerage reports suggest that new MDR-TB vaccines and products with monitorable immune responses will be key differentiation points, while integration with digital management and policy incentives is expected to create long-term market value in public health and individual disease prevention.
This report studies the global Tuberculosis Vaccine Treatment production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Tuberculosis Vaccine Treatment and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Tuberculosis Vaccine Treatment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Tuberculosis Vaccine Treatment total production and demand, 2021-2032, (K Dose)
Global Tuberculosis Vaccine Treatment total production value, 2021-2032, (USD Million)
Global Tuberculosis Vaccine Treatment production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global Tuberculosis Vaccine Treatment consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: Tuberculosis Vaccine Treatment domestic production, consumption, key domestic manufacturers and share
Global Tuberculosis Vaccine Treatment production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global Tuberculosis Vaccine Treatment production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global Tuberculosis Vaccine Treatment production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global Tuberculosis Vaccine Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, Biomed Lublin, Taj Pharmaceuticals, Ataulpho de Paiva, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Tuberculosis Vaccine Treatment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (USD/K Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Tuberculosis Vaccine Treatment Market, By Region:
1. How big is the global Tuberculosis Vaccine Treatment market?
2. What is the demand of the global Tuberculosis Vaccine Treatment market?
3. What is the year over year growth of the global Tuberculosis Vaccine Treatment market?
4. What is the production and production value of the global Tuberculosis Vaccine Treatment market?
5. Who are the key producers in the global Tuberculosis Vaccine Treatment market?
6. What are the growth factors driving the market demand?
Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Gu?rin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme. Besides, BCG Vaccine is also used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive.In 2024, global Tuberculosis Vaccine Treatment production reached approximately 318 m units, with an average global market price of around US$ 0.21 perunit
The global TB burden remains high, with WHO reporting over 10 million new cases annually, concentrated mainly in Asia and Africa, providing strong demand for tuberculosis vaccines. Governments are implementing immunization programs and public health policies to increase vaccination coverage and support new vaccine R&D through policy and funding incentives. Annual reports of leading vaccine manufacturers show sustained R&D investment, capacity expansion, and export growth, maintaining steady global market expansion. Brokerage research indicates that the need for multidrug-resistant TB (MDR-TB) prevention and new trackable vaccine management systems will further enhance vaccine penetration in public health and clinical prevention.
Tuberculosis vaccine R&D and manufacturing face challenges such as technical complexity, long clinical trial cycles, and strict regulatory approvals. Annual reports highlight that raw material supply, cold-chain logistics, and storage requirements impose high demands on cost and supply stability. Vaccination coverage in some regions is limited by insufficient public health resources, patient adherence, and vaccine accessibility, while policy adjustments, price controls, and reimbursement coverage changes may affect market revenue. Differing international regulations and approval requirements increase uncertainties for overseas market expansion.
Downstream demand is extending toward full-population and lifecycle vaccination and immunization management. Newborns and children remain the core target population, while high-risk adult protection needs are growing. Digital vaccine management and remote monitoring platforms facilitate end-to-end tracking of vaccine administration, improving adherence and efficacy evaluation. Brokerage reports suggest that new MDR-TB vaccines and products with monitorable immune responses will be key differentiation points, while integration with digital management and policy incentives is expected to create long-term market value in public health and individual disease prevention.
This report studies the global Tuberculosis Vaccine Treatment production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Tuberculosis Vaccine Treatment and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Tuberculosis Vaccine Treatment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Tuberculosis Vaccine Treatment total production and demand, 2021-2032, (K Dose)
Global Tuberculosis Vaccine Treatment total production value, 2021-2032, (USD Million)
Global Tuberculosis Vaccine Treatment production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global Tuberculosis Vaccine Treatment consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: Tuberculosis Vaccine Treatment domestic production, consumption, key domestic manufacturers and share
Global Tuberculosis Vaccine Treatment production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global Tuberculosis Vaccine Treatment production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global Tuberculosis Vaccine Treatment production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global Tuberculosis Vaccine Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, Biomed Lublin, Taj Pharmaceuticals, Ataulpho de Paiva, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Tuberculosis Vaccine Treatment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (USD/K Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Tuberculosis Vaccine Treatment Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Immune Vaccine
- Therapy Vaccine
- Self-Procurement
- UNICEF
- Other
- Merck
- Japan BCG Lab
- Serum Institute of India
- AJ Vaccines
- BioFarma
- GreenSignal Bio Pharma
- China National Biotec
- Biomed Lublin
- Taj Pharmaceuticals
- Ataulpho de Paiva
- IVAC
- Queen Saovabha Mem. Inst
- Microgen
1. How big is the global Tuberculosis Vaccine Treatment market?
2. What is the demand of the global Tuberculosis Vaccine Treatment market?
3. What is the year over year growth of the global Tuberculosis Vaccine Treatment market?
4. What is the production and production value of the global Tuberculosis Vaccine Treatment market?
5. Who are the key producers in the global Tuberculosis Vaccine Treatment market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Tuberculosis Vaccine Treatment Introduction
1.2 World Tuberculosis Vaccine Treatment Supply & Forecast
1.2.1 World Tuberculosis Vaccine Treatment Production Value (2021 & 2025 & 2032)
1.2.2 World Tuberculosis Vaccine Treatment Production (2021-2032)
1.2.3 World Tuberculosis Vaccine Treatment Pricing Trends (2021-2032)
1.3 World Tuberculosis Vaccine Treatment Production by Region (Based on Production Site)
1.3.1 World Tuberculosis Vaccine Treatment Production Value by Region (2021-2032)
1.3.2 World Tuberculosis Vaccine Treatment Production by Region (2021-2032)
1.3.3 World Tuberculosis Vaccine Treatment Average Price by Region (2021-2032)
1.3.4 North America Tuberculosis Vaccine Treatment Production (2021-2032)
1.3.5 Europe Tuberculosis Vaccine Treatment Production (2021-2032)
1.3.6 Japan Tuberculosis Vaccine Treatment Production (2021-2032)
1.3.7 China Tuberculosis Vaccine Treatment Production (2021-2032)
1.3.8 India Tuberculosis Vaccine Treatment Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Tuberculosis Vaccine Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Tuberculosis Vaccine Treatment Major Market Trends
2 DEMAND SUMMARY
2.1 World Tuberculosis Vaccine Treatment Demand (2021-2032)
2.2 World Tuberculosis Vaccine Treatment Consumption by Region
2.2.1 World Tuberculosis Vaccine Treatment Consumption by Region (2021-2026)
2.2.2 World Tuberculosis Vaccine Treatment Consumption Forecast by Region (2027-2032)
2.3 United States Tuberculosis Vaccine Treatment Consumption (2021-2032)
2.4 China Tuberculosis Vaccine Treatment Consumption (2021-2032)
2.5 Europe Tuberculosis Vaccine Treatment Consumption (2021-2032)
2.6 Japan Tuberculosis Vaccine Treatment Consumption (2021-2032)
2.7 South Korea Tuberculosis Vaccine Treatment Consumption (2021-2032)
2.8 ASEAN Tuberculosis Vaccine Treatment Consumption (2021-2032)
2.9 India Tuberculosis Vaccine Treatment Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Tuberculosis Vaccine Treatment Production Value by Manufacturer (2021-2026)
3.2 World Tuberculosis Vaccine Treatment Production by Manufacturer (2021-2026)
3.3 World Tuberculosis Vaccine Treatment Average Price by Manufacturer (2021-2026)
3.4 Tuberculosis Vaccine Treatment Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Tuberculosis Vaccine Treatment Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Tuberculosis Vaccine Treatment in 2025
3.5.3 Global Concentration Ratios (CR8) for Tuberculosis Vaccine Treatment in 2025
3.6 Tuberculosis Vaccine Treatment Market: Overall Company Footprint Analysis
3.6.1 Tuberculosis Vaccine Treatment Market: Region Footprint
3.6.2 Tuberculosis Vaccine Treatment Market: Company Product Type Footprint
3.6.3 Tuberculosis Vaccine Treatment Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Tuberculosis Vaccine Treatment Production Value Comparison
4.1.1 United States VS China: Tuberculosis Vaccine Treatment Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Tuberculosis Vaccine Treatment Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Tuberculosis Vaccine Treatment Production Comparison
4.2.1 United States VS China: Tuberculosis Vaccine Treatment Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Tuberculosis Vaccine Treatment Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Tuberculosis Vaccine Treatment Consumption Comparison
4.3.1 United States VS China: Tuberculosis Vaccine Treatment Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Tuberculosis Vaccine Treatment Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Tuberculosis Vaccine Treatment Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Tuberculosis Vaccine Treatment Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Tuberculosis Vaccine Treatment Production Value (2021-2026)
4.4.3 United States Based Manufacturers Tuberculosis Vaccine Treatment Production (2021-2026)
4.5 China Based Tuberculosis Vaccine Treatment Manufacturers and Market Share
4.5.1 China Based Tuberculosis Vaccine Treatment Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Tuberculosis Vaccine Treatment Production Value (2021-2026)
4.5.3 China Based Manufacturers Tuberculosis Vaccine Treatment Production (2021-2026)
4.6 Rest of World Based Tuberculosis Vaccine Treatment Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Tuberculosis Vaccine Treatment Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Tuberculosis Vaccine Treatment Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Tuberculosis Vaccine Treatment Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Tuberculosis Vaccine Treatment Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Immune Vaccine
5.2.2 Therapy Vaccine
5.3 Market Segment by Type
5.3.1 World Tuberculosis Vaccine Treatment Production by Type (2021-2032)
5.3.2 World Tuberculosis Vaccine Treatment Production Value by Type (2021-2032)
5.3.3 World Tuberculosis Vaccine Treatment Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Tuberculosis Vaccine Treatment Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Self-Procurement
6.2.2 UNICEF
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Tuberculosis Vaccine Treatment Production by Application (2021-2032)
6.3.2 World Tuberculosis Vaccine Treatment Production Value by Application (2021-2032)
6.3.3 World Tuberculosis Vaccine Treatment Average Price by Application (2021-2032)
7 COMPANY PROFILES
7.1 Merck
7.1.1 Merck Details
7.1.2 Merck Major Business
7.1.3 Merck Tuberculosis Vaccine Treatment Product and Services
7.1.4 Merck Tuberculosis Vaccine Treatment Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.1.5 Merck Recent Developments/Updates
7.1.6 Merck Competitive Strengths & Weaknesses
7.2 Japan BCG Lab
7.2.1 Japan BCG Lab Details
7.2.2 Japan BCG Lab Major Business
7.2.3 Japan BCG Lab Tuberculosis Vaccine Treatment Product and Services
7.2.4 Japan BCG Lab Tuberculosis Vaccine Treatment Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.2.5 Japan BCG Lab Recent Developments/Updates
7.2.6 Japan BCG Lab Competitive Strengths & Weaknesses
7.3 Serum Institute of India
7.3.1 Serum Institute of India Details
7.3.2 Serum Institute of India Major Business
7.3.3 Serum Institute of India Tuberculosis Vaccine Treatment Product and Services
7.3.4 Serum Institute of India Tuberculosis Vaccine Treatment Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.3.5 Serum Institute of India Recent Developments/Updates
7.3.6 Serum Institute of India Competitive Strengths & Weaknesses
7.4 AJ Vaccines
7.4.1 AJ Vaccines Details
7.4.2 AJ Vaccines Major Business
7.4.3 AJ Vaccines Tuberculosis Vaccine Treatment Product and Services
7.4.4 AJ Vaccines Tuberculosis Vaccine Treatment Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.4.5 AJ Vaccines Recent Developments/Updates
7.4.6 AJ Vaccines Competitive Strengths & Weaknesses
7.5 BioFarma
7.5.1 BioFarma Details
7.5.2 BioFarma Major Business
7.5.3 BioFarma Tuberculosis Vaccine Treatment Product and Services
7.5.4 BioFarma Tuberculosis Vaccine Treatment Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.5.5 BioFarma Recent Developments/Updates
7.5.6 BioFarma Competitive Strengths & Weaknesses
7.6 GreenSignal Bio Pharma
7.6.1 GreenSignal Bio Pharma Details
7.6.2 GreenSignal Bio Pharma Major Business
7.6.3 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product and Services
7.6.4 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.6.5 GreenSignal Bio Pharma Recent Developments/Updates
7.6.6 GreenSignal Bio Pharma Competitive Strengths & Weaknesses
7.7 China National Biotec
7.7.1 China National Biotec Details
7.7.2 China National Biotec Major Business
7.7.3 China National Biotec Tuberculosis Vaccine Treatment Product and Services
7.7.4 China National Biotec Tuberculosis Vaccine Treatment Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.7.5 China National Biotec Recent Developments/Updates
7.7.6 China National Biotec Competitive Strengths & Weaknesses
7.8 Biomed Lublin
7.8.1 Biomed Lublin Details
7.8.2 Biomed Lublin Major Business
7.8.3 Biomed Lublin Tuberculosis Vaccine Treatment Product and Services
7.8.4 Biomed Lublin Tuberculosis Vaccine Treatment Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.8.5 Biomed Lublin Recent Developments/Updates
7.8.6 Biomed Lublin Competitive Strengths & Weaknesses
7.9 Taj Pharmaceuticals
7.9.1 Taj Pharmaceuticals Details
7.9.2 Taj Pharmaceuticals Major Business
7.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product and Services
7.9.4 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.9.5 Taj Pharmaceuticals Recent Developments/Updates
7.9.6 Taj Pharmaceuticals Competitive Strengths & Weaknesses
7.10 Ataulpho de Paiva
7.10.1 Ataulpho de Paiva Details
7.10.2 Ataulpho de Paiva Major Business
7.10.3 Ataulpho de Paiva Tuberculosis Vaccine Treatment Product and Services
7.10.4 Ataulpho de Paiva Tuberculosis Vaccine Treatment Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.10.5 Ataulpho de Paiva Recent Developments/Updates
7.10.6 Ataulpho de Paiva Competitive Strengths & Weaknesses
7.11 IVAC
7.11.1 IVAC Details
7.11.2 IVAC Major Business
7.11.3 IVAC Tuberculosis Vaccine Treatment Product and Services
7.11.4 IVAC Tuberculosis Vaccine Treatment Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.11.5 IVAC Recent Developments/Updates
7.11.6 IVAC Competitive Strengths & Weaknesses
7.12 Queen Saovabha Mem. Inst
7.12.1 Queen Saovabha Mem. Inst Details
7.12.2 Queen Saovabha Mem. Inst Major Business
7.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product and Services
7.12.4 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.12.5 Queen Saovabha Mem. Inst Recent Developments/Updates
7.12.6 Queen Saovabha Mem. Inst Competitive Strengths & Weaknesses
7.13 Microgen
7.13.1 Microgen Details
7.13.2 Microgen Major Business
7.13.3 Microgen Tuberculosis Vaccine Treatment Product and Services
7.13.4 Microgen Tuberculosis Vaccine Treatment Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.13.5 Microgen Recent Developments/Updates
7.13.6 Microgen Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Tuberculosis Vaccine Treatment Industry Chain
8.2 Tuberculosis Vaccine Treatment Upstream Analysis
8.2.1 Tuberculosis Vaccine Treatment Core Raw Materials
8.2.2 Main Manufacturers of Tuberculosis Vaccine Treatment Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Tuberculosis Vaccine Treatment Production Mode
8.6 Tuberculosis Vaccine Treatment Procurement Model
8.7 Tuberculosis Vaccine Treatment Industry Sales Model and Sales Channels
8.7.1 Tuberculosis Vaccine Treatment Sales Model
8.7.2 Tuberculosis Vaccine Treatment Typical Distributors
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Tuberculosis Vaccine Treatment Introduction
1.2 World Tuberculosis Vaccine Treatment Supply & Forecast
1.2.1 World Tuberculosis Vaccine Treatment Production Value (2021 & 2025 & 2032)
1.2.2 World Tuberculosis Vaccine Treatment Production (2021-2032)
1.2.3 World Tuberculosis Vaccine Treatment Pricing Trends (2021-2032)
1.3 World Tuberculosis Vaccine Treatment Production by Region (Based on Production Site)
1.3.1 World Tuberculosis Vaccine Treatment Production Value by Region (2021-2032)
1.3.2 World Tuberculosis Vaccine Treatment Production by Region (2021-2032)
1.3.3 World Tuberculosis Vaccine Treatment Average Price by Region (2021-2032)
1.3.4 North America Tuberculosis Vaccine Treatment Production (2021-2032)
1.3.5 Europe Tuberculosis Vaccine Treatment Production (2021-2032)
1.3.6 Japan Tuberculosis Vaccine Treatment Production (2021-2032)
1.3.7 China Tuberculosis Vaccine Treatment Production (2021-2032)
1.3.8 India Tuberculosis Vaccine Treatment Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Tuberculosis Vaccine Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Tuberculosis Vaccine Treatment Major Market Trends
2 DEMAND SUMMARY
2.1 World Tuberculosis Vaccine Treatment Demand (2021-2032)
2.2 World Tuberculosis Vaccine Treatment Consumption by Region
2.2.1 World Tuberculosis Vaccine Treatment Consumption by Region (2021-2026)
2.2.2 World Tuberculosis Vaccine Treatment Consumption Forecast by Region (2027-2032)
2.3 United States Tuberculosis Vaccine Treatment Consumption (2021-2032)
2.4 China Tuberculosis Vaccine Treatment Consumption (2021-2032)
2.5 Europe Tuberculosis Vaccine Treatment Consumption (2021-2032)
2.6 Japan Tuberculosis Vaccine Treatment Consumption (2021-2032)
2.7 South Korea Tuberculosis Vaccine Treatment Consumption (2021-2032)
2.8 ASEAN Tuberculosis Vaccine Treatment Consumption (2021-2032)
2.9 India Tuberculosis Vaccine Treatment Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Tuberculosis Vaccine Treatment Production Value by Manufacturer (2021-2026)
3.2 World Tuberculosis Vaccine Treatment Production by Manufacturer (2021-2026)
3.3 World Tuberculosis Vaccine Treatment Average Price by Manufacturer (2021-2026)
3.4 Tuberculosis Vaccine Treatment Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Tuberculosis Vaccine Treatment Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Tuberculosis Vaccine Treatment in 2025
3.5.3 Global Concentration Ratios (CR8) for Tuberculosis Vaccine Treatment in 2025
3.6 Tuberculosis Vaccine Treatment Market: Overall Company Footprint Analysis
3.6.1 Tuberculosis Vaccine Treatment Market: Region Footprint
3.6.2 Tuberculosis Vaccine Treatment Market: Company Product Type Footprint
3.6.3 Tuberculosis Vaccine Treatment Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Tuberculosis Vaccine Treatment Production Value Comparison
4.1.1 United States VS China: Tuberculosis Vaccine Treatment Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Tuberculosis Vaccine Treatment Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Tuberculosis Vaccine Treatment Production Comparison
4.2.1 United States VS China: Tuberculosis Vaccine Treatment Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Tuberculosis Vaccine Treatment Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Tuberculosis Vaccine Treatment Consumption Comparison
4.3.1 United States VS China: Tuberculosis Vaccine Treatment Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Tuberculosis Vaccine Treatment Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Tuberculosis Vaccine Treatment Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Tuberculosis Vaccine Treatment Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Tuberculosis Vaccine Treatment Production Value (2021-2026)
4.4.3 United States Based Manufacturers Tuberculosis Vaccine Treatment Production (2021-2026)
4.5 China Based Tuberculosis Vaccine Treatment Manufacturers and Market Share
4.5.1 China Based Tuberculosis Vaccine Treatment Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Tuberculosis Vaccine Treatment Production Value (2021-2026)
4.5.3 China Based Manufacturers Tuberculosis Vaccine Treatment Production (2021-2026)
4.6 Rest of World Based Tuberculosis Vaccine Treatment Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Tuberculosis Vaccine Treatment Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Tuberculosis Vaccine Treatment Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Tuberculosis Vaccine Treatment Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Tuberculosis Vaccine Treatment Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Immune Vaccine
5.2.2 Therapy Vaccine
5.3 Market Segment by Type
5.3.1 World Tuberculosis Vaccine Treatment Production by Type (2021-2032)
5.3.2 World Tuberculosis Vaccine Treatment Production Value by Type (2021-2032)
5.3.3 World Tuberculosis Vaccine Treatment Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Tuberculosis Vaccine Treatment Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Self-Procurement
6.2.2 UNICEF
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Tuberculosis Vaccine Treatment Production by Application (2021-2032)
6.3.2 World Tuberculosis Vaccine Treatment Production Value by Application (2021-2032)
6.3.3 World Tuberculosis Vaccine Treatment Average Price by Application (2021-2032)
7 COMPANY PROFILES
7.1 Merck
7.1.1 Merck Details
7.1.2 Merck Major Business
7.1.3 Merck Tuberculosis Vaccine Treatment Product and Services
7.1.4 Merck Tuberculosis Vaccine Treatment Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.1.5 Merck Recent Developments/Updates
7.1.6 Merck Competitive Strengths & Weaknesses
7.2 Japan BCG Lab
7.2.1 Japan BCG Lab Details
7.2.2 Japan BCG Lab Major Business
7.2.3 Japan BCG Lab Tuberculosis Vaccine Treatment Product and Services
7.2.4 Japan BCG Lab Tuberculosis Vaccine Treatment Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.2.5 Japan BCG Lab Recent Developments/Updates
7.2.6 Japan BCG Lab Competitive Strengths & Weaknesses
7.3 Serum Institute of India
7.3.1 Serum Institute of India Details
7.3.2 Serum Institute of India Major Business
7.3.3 Serum Institute of India Tuberculosis Vaccine Treatment Product and Services
7.3.4 Serum Institute of India Tuberculosis Vaccine Treatment Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.3.5 Serum Institute of India Recent Developments/Updates
7.3.6 Serum Institute of India Competitive Strengths & Weaknesses
7.4 AJ Vaccines
7.4.1 AJ Vaccines Details
7.4.2 AJ Vaccines Major Business
7.4.3 AJ Vaccines Tuberculosis Vaccine Treatment Product and Services
7.4.4 AJ Vaccines Tuberculosis Vaccine Treatment Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.4.5 AJ Vaccines Recent Developments/Updates
7.4.6 AJ Vaccines Competitive Strengths & Weaknesses
7.5 BioFarma
7.5.1 BioFarma Details
7.5.2 BioFarma Major Business
7.5.3 BioFarma Tuberculosis Vaccine Treatment Product and Services
7.5.4 BioFarma Tuberculosis Vaccine Treatment Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.5.5 BioFarma Recent Developments/Updates
7.5.6 BioFarma Competitive Strengths & Weaknesses
7.6 GreenSignal Bio Pharma
7.6.1 GreenSignal Bio Pharma Details
7.6.2 GreenSignal Bio Pharma Major Business
7.6.3 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product and Services
7.6.4 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.6.5 GreenSignal Bio Pharma Recent Developments/Updates
7.6.6 GreenSignal Bio Pharma Competitive Strengths & Weaknesses
7.7 China National Biotec
7.7.1 China National Biotec Details
7.7.2 China National Biotec Major Business
7.7.3 China National Biotec Tuberculosis Vaccine Treatment Product and Services
7.7.4 China National Biotec Tuberculosis Vaccine Treatment Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.7.5 China National Biotec Recent Developments/Updates
7.7.6 China National Biotec Competitive Strengths & Weaknesses
7.8 Biomed Lublin
7.8.1 Biomed Lublin Details
7.8.2 Biomed Lublin Major Business
7.8.3 Biomed Lublin Tuberculosis Vaccine Treatment Product and Services
7.8.4 Biomed Lublin Tuberculosis Vaccine Treatment Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.8.5 Biomed Lublin Recent Developments/Updates
7.8.6 Biomed Lublin Competitive Strengths & Weaknesses
7.9 Taj Pharmaceuticals
7.9.1 Taj Pharmaceuticals Details
7.9.2 Taj Pharmaceuticals Major Business
7.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product and Services
7.9.4 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.9.5 Taj Pharmaceuticals Recent Developments/Updates
7.9.6 Taj Pharmaceuticals Competitive Strengths & Weaknesses
7.10 Ataulpho de Paiva
7.10.1 Ataulpho de Paiva Details
7.10.2 Ataulpho de Paiva Major Business
7.10.3 Ataulpho de Paiva Tuberculosis Vaccine Treatment Product and Services
7.10.4 Ataulpho de Paiva Tuberculosis Vaccine Treatment Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.10.5 Ataulpho de Paiva Recent Developments/Updates
7.10.6 Ataulpho de Paiva Competitive Strengths & Weaknesses
7.11 IVAC
7.11.1 IVAC Details
7.11.2 IVAC Major Business
7.11.3 IVAC Tuberculosis Vaccine Treatment Product and Services
7.11.4 IVAC Tuberculosis Vaccine Treatment Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.11.5 IVAC Recent Developments/Updates
7.11.6 IVAC Competitive Strengths & Weaknesses
7.12 Queen Saovabha Mem. Inst
7.12.1 Queen Saovabha Mem. Inst Details
7.12.2 Queen Saovabha Mem. Inst Major Business
7.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product and Services
7.12.4 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.12.5 Queen Saovabha Mem. Inst Recent Developments/Updates
7.12.6 Queen Saovabha Mem. Inst Competitive Strengths & Weaknesses
7.13 Microgen
7.13.1 Microgen Details
7.13.2 Microgen Major Business
7.13.3 Microgen Tuberculosis Vaccine Treatment Product and Services
7.13.4 Microgen Tuberculosis Vaccine Treatment Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.13.5 Microgen Recent Developments/Updates
7.13.6 Microgen Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Tuberculosis Vaccine Treatment Industry Chain
8.2 Tuberculosis Vaccine Treatment Upstream Analysis
8.2.1 Tuberculosis Vaccine Treatment Core Raw Materials
8.2.2 Main Manufacturers of Tuberculosis Vaccine Treatment Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Tuberculosis Vaccine Treatment Production Mode
8.6 Tuberculosis Vaccine Treatment Procurement Model
8.7 Tuberculosis Vaccine Treatment Industry Sales Model and Sales Channels
8.7.1 Tuberculosis Vaccine Treatment Sales Model
8.7.2 Tuberculosis Vaccine Treatment Typical Distributors
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF FIGURES
Table 1. World Tuberculosis Vaccine Treatment Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Tuberculosis Vaccine Treatment Production Value by Region (2021-2026) & (USD Million)
Table 3. World Tuberculosis Vaccine Treatment Production Value by Region (2027-2032) & (USD Million)
Table 4. World Tuberculosis Vaccine Treatment Production Value Market Share by Region (2021-2026)
Table 5. World Tuberculosis Vaccine Treatment Production Value Market Share by Region (2027-2032)
Table 6. World Tuberculosis Vaccine Treatment Production by Region (2021-2026) & (K Dose)
Table 7. World Tuberculosis Vaccine Treatment Production by Region (2027-2032) & (K Dose)
Table 8. World Tuberculosis Vaccine Treatment Production Market Share by Region (2021-2026)
Table 9. World Tuberculosis Vaccine Treatment Production Market Share by Region (2027-2032)
Table 10. World Tuberculosis Vaccine Treatment Average Price by Region (2021-2026) & (USD/K Dose)
Table 11. World Tuberculosis Vaccine Treatment Average Price by Region (2027-2032) & (USD/K Dose)
Table 12. Tuberculosis Vaccine Treatment Major Market Trends
Table 13. World Tuberculosis Vaccine Treatment Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World Tuberculosis Vaccine Treatment Consumption by Region (2021-2026) & (K Dose)
Table 15. World Tuberculosis Vaccine Treatment Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World Tuberculosis Vaccine Treatment Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Tuberculosis Vaccine Treatment Producers in 2025
Table 18. World Tuberculosis Vaccine Treatment Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key Tuberculosis Vaccine Treatment Producers in 2025
Table 20. World Tuberculosis Vaccine Treatment Average Price by Manufacturer (2021-2026) & (USD/K Dose)
Table 21. Global Tuberculosis Vaccine Treatment Company Evaluation Quadrant
Table 22. World Tuberculosis Vaccine Treatment Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Tuberculosis Vaccine Treatment Production Site of Key Manufacturer
Table 24. Tuberculosis Vaccine Treatment Market: Company Product Type Footprint
Table 25. Tuberculosis Vaccine Treatment Market: Company Product Application Footprint
Table 26. Tuberculosis Vaccine Treatment Competitive Factors
Table 27. Tuberculosis Vaccine Treatment New Entrant and Capacity Expansion Plans
Table 28. Tuberculosis Vaccine Treatment Mergers & Acquisitions Activity
Table 29. United States VS China Tuberculosis Vaccine Treatment Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Tuberculosis Vaccine Treatment Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China Tuberculosis Vaccine Treatment Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based Tuberculosis Vaccine Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Tuberculosis Vaccine Treatment Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Tuberculosis Vaccine Treatment Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Tuberculosis Vaccine Treatment Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers Tuberculosis Vaccine Treatment Production Market Share (2021-2026)
Table 37. China Based Tuberculosis Vaccine Treatment Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Tuberculosis Vaccine Treatment Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Tuberculosis Vaccine Treatment Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Tuberculosis Vaccine Treatment Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers Tuberculosis Vaccine Treatment Production Market Share (2021-2026)
Table 42. Rest of World Based Tuberculosis Vaccine Treatment Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Tuberculosis Vaccine Treatment Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Tuberculosis Vaccine Treatment Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Tuberculosis Vaccine Treatment Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers Tuberculosis Vaccine Treatment Production Market Share (2021-2026)
Table 47. World Tuberculosis Vaccine Treatment Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Tuberculosis Vaccine Treatment Production by Type (2021-2026) & (K Dose)
Table 49. World Tuberculosis Vaccine Treatment Production by Type (2027-2032) & (K Dose)
Table 50. World Tuberculosis Vaccine Treatment Production Value by Type (2021-2026) & (USD Million)
Table 51. World Tuberculosis Vaccine Treatment Production Value by Type (2027-2032) & (USD Million)
Table 52. World Tuberculosis Vaccine Treatment Average Price by Type (2021-2026) & (USD/K Dose)
Table 53. World Tuberculosis Vaccine Treatment Average Price by Type (2027-2032) & (USD/K Dose)
Table 54. World Tuberculosis Vaccine Treatment Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 55. World Tuberculosis Vaccine Treatment Production by Application (2021-2026) & (K Dose)
Table 56. World Tuberculosis Vaccine Treatment Production by Application (2027-2032) & (K Dose)
Table 57. World Tuberculosis Vaccine Treatment Production Value by Application (2021-2026) & (USD Million)
Table 58. World Tuberculosis Vaccine Treatment Production Value by Application (2027-2032) & (USD Million)
Table 59. World Tuberculosis Vaccine Treatment Average Price by Application (2021-2026) & (USD/K Dose)
Table 60. World Tuberculosis Vaccine Treatment Average Price by Application (2027-2032) & (USD/K Dose)
Table 61. Merck Basic Information, Manufacturing Base and Competitors
Table 62. Merck Major Business
Table 63. Merck Tuberculosis Vaccine Treatment Product and Services
Table 64. Merck Tuberculosis Vaccine Treatment Production (K Dose), Price (USD/K Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Merck Recent Developments/Updates
Table 66. Merck Competitive Strengths & Weaknesses
Table 67. Japan BCG Lab Basic Information, Manufacturing Base and Competitors
Table 68. Japan BCG Lab Major Business
Table 69. Japan BCG Lab Tuberculosis Vaccine Treatment Product and Services
Table 70. Japan BCG Lab Tuberculosis Vaccine Treatment Production (K Dose), Price (USD/K Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 71. Japan BCG Lab Recent Developments/Updates
Table 72. Japan BCG Lab Competitive Strengths & Weaknesses
Table 73. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 74. Serum Institute of India Major Business
Table 75. Serum Institute of India Tuberculosis Vaccine Treatment Product and Services
Table 76. Serum Institute of India Tuberculosis Vaccine Treatment Production (K Dose), Price (USD/K Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. Serum Institute of India Recent Developments/Updates
Table 78. Serum Institute of India Competitive Strengths & Weaknesses
Table 79. AJ Vaccines Basic Information, Manufacturing Base and Competitors
Table 80. AJ Vaccines Major Business
Table 81. AJ Vaccines Tuberculosis Vaccine Treatment Product and Services
Table 82. AJ Vaccines Tuberculosis Vaccine Treatment Production (K Dose), Price (USD/K Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. AJ Vaccines Recent Developments/Updates
Table 84. AJ Vaccines Competitive Strengths & Weaknesses
Table 85. BioFarma Basic Information, Manufacturing Base and Competitors
Table 86. BioFarma Major Business
Table 87. BioFarma Tuberculosis Vaccine Treatment Product and Services
Table 88. BioFarma Tuberculosis Vaccine Treatment Production (K Dose), Price (USD/K Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. BioFarma Recent Developments/Updates
Table 90. BioFarma Competitive Strengths & Weaknesses
Table 91. GreenSignal Bio Pharma Basic Information, Manufacturing Base and Competitors
Table 92. GreenSignal Bio Pharma Major Business
Table 93. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product and Services
Table 94. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Production (K Dose), Price (USD/K Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. GreenSignal Bio Pharma Recent Developments/Updates
Table 96. GreenSignal Bio Pharma Competitive Strengths & Weaknesses
Table 97. China National Biotec Basic Information, Manufacturing Base and Competitors
Table 98. China National Biotec Major Business
Table 99. China National Biotec Tuberculosis Vaccine Treatment Product and Services
Table 100. China National Biotec Tuberculosis Vaccine Treatment Production (K Dose), Price (USD/K Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 101. China National Biotec Recent Developments/Updates
Table 102. China National Biotec Competitive Strengths & Weaknesses
Table 103. Biomed Lublin Basic Information, Manufacturing Base and Competitors
Table 104. Biomed Lublin Major Business
Table 105. Biomed Lublin Tuberculosis Vaccine Treatment Product and Services
Table 106. Biomed Lublin Tuberculosis Vaccine Treatment Production (K Dose), Price (USD/K Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 107. Biomed Lublin Recent Developments/Updates
Table 108. Biomed Lublin Competitive Strengths & Weaknesses
Table 109. Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 110. Taj Pharmaceuticals Major Business
Table 111. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product and Services
Table 112. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Production (K Dose), Price (USD/K Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 113. Taj Pharmaceuticals Recent Developments/Updates
Table 114. Taj Pharmaceuticals Competitive Strengths & Weaknesses
Table 115. Ataulpho de Paiva Basic Information, Manufacturing Base and Competitors
Table 116. Ataulpho de Paiva Major Business
Table 117. Ataulpho de Paiva Tuberculosis Vaccine Treatment Product and Services
Table 118. Ataulpho de Paiva Tuberculosis Vaccine Treatment Production (K Dose), Price (USD/K Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 119. Ataulpho de Paiva Recent Developments/Updates
Table 120. Ataulpho de Paiva Competitive Strengths & Weaknesses
Table 121. IVAC Basic Information, Manufacturing Base and Competitors
Table 122. IVAC Major Business
Table 123. IVAC Tuberculosis Vaccine Treatment Product and Services
Table 124. IVAC Tuberculosis Vaccine Treatment Production (K Dose), Price (USD/K Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. IVAC Recent Developments/Updates
Table 126. IVAC Competitive Strengths & Weaknesses
Table 127. Queen Saovabha Mem. Inst Basic Information, Manufacturing Base and Competitors
Table 128. Queen Saovabha Mem. Inst Major Business
Table 129. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product and Services
Table 130. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Production (K Dose), Price (USD/K Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 131. Queen Saovabha Mem. Inst Recent Developments/Updates
Table 132. Queen Saovabha Mem. Inst Competitive Strengths & Weaknesses
Table 133. Microgen Basic Information, Manufacturing Base and Competitors
Table 134. Microgen Major Business
Table 135. Microgen Tuberculosis Vaccine Treatment Product and Services
Table 136. Microgen Tuberculosis Vaccine Treatment Production (K Dose), Price (USD/K Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 137. Microgen Recent Developments/Updates
Table 138. Microgen Competitive Strengths & Weaknesses
Table 139. Global Key Players of Tuberculosis Vaccine Treatment Upstream (Raw Materials)
Table 140. Global Tuberculosis Vaccine Treatment Typical Customers
Table 141. Tuberculosis Vaccine Treatment Typical Distributors
LIST OF FIGURES
Figure 1. Tuberculosis Vaccine Treatment Picture
Figure 2. World Tuberculosis Vaccine Treatment Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Tuberculosis Vaccine Treatment Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Tuberculosis Vaccine Treatment Production (2021-2032) & (K Dose)
Figure 5. World Tuberculosis Vaccine Treatment Average Price (2021-2032) & (USD/K Dose)
Figure 6. World Tuberculosis Vaccine Treatment Production Value Market Share by Region (2021-2032)
Figure 7. World Tuberculosis Vaccine Treatment Production Market Share by Region (2021-2032)
Figure 8. North America Tuberculosis Vaccine Treatment Production (2021-2032) & (K Dose)
Figure 9. Europe Tuberculosis Vaccine Treatment Production (2021-2032) & (K Dose)
Figure 10. Japan Tuberculosis Vaccine Treatment Production (2021-2032) & (K Dose)
Figure 11. China Tuberculosis Vaccine Treatment Production (2021-2032) & (K Dose)
Figure 12. India Tuberculosis Vaccine Treatment Production (2021-2032) & (K Dose)
Figure 13. Tuberculosis Vaccine Treatment Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Tuberculosis Vaccine Treatment Consumption (2021-2032) & (K Dose)
Figure 16. World Tuberculosis Vaccine Treatment Consumption Market Share by Region (2021-2032)
Figure 17. United States Tuberculosis Vaccine Treatment Consumption (2021-2032) & (K Dose)
Figure 18. China Tuberculosis Vaccine Treatment Consumption (2021-2032) & (K Dose)
Figure 19. Europe Tuberculosis Vaccine Treatment Consumption (2021-2032) & (K Dose)
Figure 20. Japan Tuberculosis Vaccine Treatment Consumption (2021-2032) & (K Dose)
Figure 21. South Korea Tuberculosis Vaccine Treatment Consumption (2021-2032) & (K Dose)
Figure 22. ASEAN Tuberculosis Vaccine Treatment Consumption (2021-2032) & (K Dose)
Figure 23. India Tuberculosis Vaccine Treatment Consumption (2021-2032) & (K Dose)
Figure 24. Producer Shipments of Tuberculosis Vaccine Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Tuberculosis Vaccine Treatment Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Tuberculosis Vaccine Treatment Markets in 2025
Figure 27. United States VS China: Tuberculosis Vaccine Treatment Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Tuberculosis Vaccine Treatment Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Tuberculosis Vaccine Treatment Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Tuberculosis Vaccine Treatment Production Market Share 2025
Figure 31. China Based Manufacturers Tuberculosis Vaccine Treatment Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Tuberculosis Vaccine Treatment Production Market Share 2025
Figure 33. World Tuberculosis Vaccine Treatment Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Tuberculosis Vaccine Treatment Production Value Market Share by Type in 2025
Figure 35. Immune Vaccine
Figure 36. Therapy Vaccine
Figure 37. World Tuberculosis Vaccine Treatment Production Market Share by Type (2021-2032)
Figure 38. World Tuberculosis Vaccine Treatment Production Value Market Share by Type (2021-2032)
Figure 39. World Tuberculosis Vaccine Treatment Average Price by Type (2021-2032) & (USD/K Dose)
Figure 40. World Tuberculosis Vaccine Treatment Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 41. World Tuberculosis Vaccine Treatment Production Value Market Share by Application in 2025
Figure 42. Self-Procurement
Figure 43. UNICEF
Figure 44. Other
Figure 45. World Tuberculosis Vaccine Treatment Production Market Share by Application (2021-2032)
Figure 46. World Tuberculosis Vaccine Treatment Production Value Market Share by Application (2021-2032)
Figure 47. World Tuberculosis Vaccine Treatment Average Price by Application (2021-2032) & (USD/K Dose)
Figure 48. Tuberculosis Vaccine Treatment Industry Chain
Figure 49. Tuberculosis Vaccine Treatment Procurement Model
Figure 50. Tuberculosis Vaccine Treatment Sales Model
Figure 51. Tuberculosis Vaccine Treatment Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Table 1. World Tuberculosis Vaccine Treatment Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Tuberculosis Vaccine Treatment Production Value by Region (2021-2026) & (USD Million)
Table 3. World Tuberculosis Vaccine Treatment Production Value by Region (2027-2032) & (USD Million)
Table 4. World Tuberculosis Vaccine Treatment Production Value Market Share by Region (2021-2026)
Table 5. World Tuberculosis Vaccine Treatment Production Value Market Share by Region (2027-2032)
Table 6. World Tuberculosis Vaccine Treatment Production by Region (2021-2026) & (K Dose)
Table 7. World Tuberculosis Vaccine Treatment Production by Region (2027-2032) & (K Dose)
Table 8. World Tuberculosis Vaccine Treatment Production Market Share by Region (2021-2026)
Table 9. World Tuberculosis Vaccine Treatment Production Market Share by Region (2027-2032)
Table 10. World Tuberculosis Vaccine Treatment Average Price by Region (2021-2026) & (USD/K Dose)
Table 11. World Tuberculosis Vaccine Treatment Average Price by Region (2027-2032) & (USD/K Dose)
Table 12. Tuberculosis Vaccine Treatment Major Market Trends
Table 13. World Tuberculosis Vaccine Treatment Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World Tuberculosis Vaccine Treatment Consumption by Region (2021-2026) & (K Dose)
Table 15. World Tuberculosis Vaccine Treatment Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World Tuberculosis Vaccine Treatment Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Tuberculosis Vaccine Treatment Producers in 2025
Table 18. World Tuberculosis Vaccine Treatment Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key Tuberculosis Vaccine Treatment Producers in 2025
Table 20. World Tuberculosis Vaccine Treatment Average Price by Manufacturer (2021-2026) & (USD/K Dose)
Table 21. Global Tuberculosis Vaccine Treatment Company Evaluation Quadrant
Table 22. World Tuberculosis Vaccine Treatment Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Tuberculosis Vaccine Treatment Production Site of Key Manufacturer
Table 24. Tuberculosis Vaccine Treatment Market: Company Product Type Footprint
Table 25. Tuberculosis Vaccine Treatment Market: Company Product Application Footprint
Table 26. Tuberculosis Vaccine Treatment Competitive Factors
Table 27. Tuberculosis Vaccine Treatment New Entrant and Capacity Expansion Plans
Table 28. Tuberculosis Vaccine Treatment Mergers & Acquisitions Activity
Table 29. United States VS China Tuberculosis Vaccine Treatment Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Tuberculosis Vaccine Treatment Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China Tuberculosis Vaccine Treatment Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based Tuberculosis Vaccine Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Tuberculosis Vaccine Treatment Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Tuberculosis Vaccine Treatment Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Tuberculosis Vaccine Treatment Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers Tuberculosis Vaccine Treatment Production Market Share (2021-2026)
Table 37. China Based Tuberculosis Vaccine Treatment Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Tuberculosis Vaccine Treatment Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Tuberculosis Vaccine Treatment Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Tuberculosis Vaccine Treatment Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers Tuberculosis Vaccine Treatment Production Market Share (2021-2026)
Table 42. Rest of World Based Tuberculosis Vaccine Treatment Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Tuberculosis Vaccine Treatment Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Tuberculosis Vaccine Treatment Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Tuberculosis Vaccine Treatment Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers Tuberculosis Vaccine Treatment Production Market Share (2021-2026)
Table 47. World Tuberculosis Vaccine Treatment Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Tuberculosis Vaccine Treatment Production by Type (2021-2026) & (K Dose)
Table 49. World Tuberculosis Vaccine Treatment Production by Type (2027-2032) & (K Dose)
Table 50. World Tuberculosis Vaccine Treatment Production Value by Type (2021-2026) & (USD Million)
Table 51. World Tuberculosis Vaccine Treatment Production Value by Type (2027-2032) & (USD Million)
Table 52. World Tuberculosis Vaccine Treatment Average Price by Type (2021-2026) & (USD/K Dose)
Table 53. World Tuberculosis Vaccine Treatment Average Price by Type (2027-2032) & (USD/K Dose)
Table 54. World Tuberculosis Vaccine Treatment Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 55. World Tuberculosis Vaccine Treatment Production by Application (2021-2026) & (K Dose)
Table 56. World Tuberculosis Vaccine Treatment Production by Application (2027-2032) & (K Dose)
Table 57. World Tuberculosis Vaccine Treatment Production Value by Application (2021-2026) & (USD Million)
Table 58. World Tuberculosis Vaccine Treatment Production Value by Application (2027-2032) & (USD Million)
Table 59. World Tuberculosis Vaccine Treatment Average Price by Application (2021-2026) & (USD/K Dose)
Table 60. World Tuberculosis Vaccine Treatment Average Price by Application (2027-2032) & (USD/K Dose)
Table 61. Merck Basic Information, Manufacturing Base and Competitors
Table 62. Merck Major Business
Table 63. Merck Tuberculosis Vaccine Treatment Product and Services
Table 64. Merck Tuberculosis Vaccine Treatment Production (K Dose), Price (USD/K Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Merck Recent Developments/Updates
Table 66. Merck Competitive Strengths & Weaknesses
Table 67. Japan BCG Lab Basic Information, Manufacturing Base and Competitors
Table 68. Japan BCG Lab Major Business
Table 69. Japan BCG Lab Tuberculosis Vaccine Treatment Product and Services
Table 70. Japan BCG Lab Tuberculosis Vaccine Treatment Production (K Dose), Price (USD/K Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 71. Japan BCG Lab Recent Developments/Updates
Table 72. Japan BCG Lab Competitive Strengths & Weaknesses
Table 73. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 74. Serum Institute of India Major Business
Table 75. Serum Institute of India Tuberculosis Vaccine Treatment Product and Services
Table 76. Serum Institute of India Tuberculosis Vaccine Treatment Production (K Dose), Price (USD/K Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. Serum Institute of India Recent Developments/Updates
Table 78. Serum Institute of India Competitive Strengths & Weaknesses
Table 79. AJ Vaccines Basic Information, Manufacturing Base and Competitors
Table 80. AJ Vaccines Major Business
Table 81. AJ Vaccines Tuberculosis Vaccine Treatment Product and Services
Table 82. AJ Vaccines Tuberculosis Vaccine Treatment Production (K Dose), Price (USD/K Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. AJ Vaccines Recent Developments/Updates
Table 84. AJ Vaccines Competitive Strengths & Weaknesses
Table 85. BioFarma Basic Information, Manufacturing Base and Competitors
Table 86. BioFarma Major Business
Table 87. BioFarma Tuberculosis Vaccine Treatment Product and Services
Table 88. BioFarma Tuberculosis Vaccine Treatment Production (K Dose), Price (USD/K Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. BioFarma Recent Developments/Updates
Table 90. BioFarma Competitive Strengths & Weaknesses
Table 91. GreenSignal Bio Pharma Basic Information, Manufacturing Base and Competitors
Table 92. GreenSignal Bio Pharma Major Business
Table 93. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product and Services
Table 94. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Production (K Dose), Price (USD/K Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. GreenSignal Bio Pharma Recent Developments/Updates
Table 96. GreenSignal Bio Pharma Competitive Strengths & Weaknesses
Table 97. China National Biotec Basic Information, Manufacturing Base and Competitors
Table 98. China National Biotec Major Business
Table 99. China National Biotec Tuberculosis Vaccine Treatment Product and Services
Table 100. China National Biotec Tuberculosis Vaccine Treatment Production (K Dose), Price (USD/K Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 101. China National Biotec Recent Developments/Updates
Table 102. China National Biotec Competitive Strengths & Weaknesses
Table 103. Biomed Lublin Basic Information, Manufacturing Base and Competitors
Table 104. Biomed Lublin Major Business
Table 105. Biomed Lublin Tuberculosis Vaccine Treatment Product and Services
Table 106. Biomed Lublin Tuberculosis Vaccine Treatment Production (K Dose), Price (USD/K Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 107. Biomed Lublin Recent Developments/Updates
Table 108. Biomed Lublin Competitive Strengths & Weaknesses
Table 109. Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 110. Taj Pharmaceuticals Major Business
Table 111. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product and Services
Table 112. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Production (K Dose), Price (USD/K Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 113. Taj Pharmaceuticals Recent Developments/Updates
Table 114. Taj Pharmaceuticals Competitive Strengths & Weaknesses
Table 115. Ataulpho de Paiva Basic Information, Manufacturing Base and Competitors
Table 116. Ataulpho de Paiva Major Business
Table 117. Ataulpho de Paiva Tuberculosis Vaccine Treatment Product and Services
Table 118. Ataulpho de Paiva Tuberculosis Vaccine Treatment Production (K Dose), Price (USD/K Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 119. Ataulpho de Paiva Recent Developments/Updates
Table 120. Ataulpho de Paiva Competitive Strengths & Weaknesses
Table 121. IVAC Basic Information, Manufacturing Base and Competitors
Table 122. IVAC Major Business
Table 123. IVAC Tuberculosis Vaccine Treatment Product and Services
Table 124. IVAC Tuberculosis Vaccine Treatment Production (K Dose), Price (USD/K Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. IVAC Recent Developments/Updates
Table 126. IVAC Competitive Strengths & Weaknesses
Table 127. Queen Saovabha Mem. Inst Basic Information, Manufacturing Base and Competitors
Table 128. Queen Saovabha Mem. Inst Major Business
Table 129. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product and Services
Table 130. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Production (K Dose), Price (USD/K Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 131. Queen Saovabha Mem. Inst Recent Developments/Updates
Table 132. Queen Saovabha Mem. Inst Competitive Strengths & Weaknesses
Table 133. Microgen Basic Information, Manufacturing Base and Competitors
Table 134. Microgen Major Business
Table 135. Microgen Tuberculosis Vaccine Treatment Product and Services
Table 136. Microgen Tuberculosis Vaccine Treatment Production (K Dose), Price (USD/K Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 137. Microgen Recent Developments/Updates
Table 138. Microgen Competitive Strengths & Weaknesses
Table 139. Global Key Players of Tuberculosis Vaccine Treatment Upstream (Raw Materials)
Table 140. Global Tuberculosis Vaccine Treatment Typical Customers
Table 141. Tuberculosis Vaccine Treatment Typical Distributors
LIST OF FIGURES
Figure 1. Tuberculosis Vaccine Treatment Picture
Figure 2. World Tuberculosis Vaccine Treatment Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Tuberculosis Vaccine Treatment Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Tuberculosis Vaccine Treatment Production (2021-2032) & (K Dose)
Figure 5. World Tuberculosis Vaccine Treatment Average Price (2021-2032) & (USD/K Dose)
Figure 6. World Tuberculosis Vaccine Treatment Production Value Market Share by Region (2021-2032)
Figure 7. World Tuberculosis Vaccine Treatment Production Market Share by Region (2021-2032)
Figure 8. North America Tuberculosis Vaccine Treatment Production (2021-2032) & (K Dose)
Figure 9. Europe Tuberculosis Vaccine Treatment Production (2021-2032) & (K Dose)
Figure 10. Japan Tuberculosis Vaccine Treatment Production (2021-2032) & (K Dose)
Figure 11. China Tuberculosis Vaccine Treatment Production (2021-2032) & (K Dose)
Figure 12. India Tuberculosis Vaccine Treatment Production (2021-2032) & (K Dose)
Figure 13. Tuberculosis Vaccine Treatment Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Tuberculosis Vaccine Treatment Consumption (2021-2032) & (K Dose)
Figure 16. World Tuberculosis Vaccine Treatment Consumption Market Share by Region (2021-2032)
Figure 17. United States Tuberculosis Vaccine Treatment Consumption (2021-2032) & (K Dose)
Figure 18. China Tuberculosis Vaccine Treatment Consumption (2021-2032) & (K Dose)
Figure 19. Europe Tuberculosis Vaccine Treatment Consumption (2021-2032) & (K Dose)
Figure 20. Japan Tuberculosis Vaccine Treatment Consumption (2021-2032) & (K Dose)
Figure 21. South Korea Tuberculosis Vaccine Treatment Consumption (2021-2032) & (K Dose)
Figure 22. ASEAN Tuberculosis Vaccine Treatment Consumption (2021-2032) & (K Dose)
Figure 23. India Tuberculosis Vaccine Treatment Consumption (2021-2032) & (K Dose)
Figure 24. Producer Shipments of Tuberculosis Vaccine Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Tuberculosis Vaccine Treatment Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Tuberculosis Vaccine Treatment Markets in 2025
Figure 27. United States VS China: Tuberculosis Vaccine Treatment Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Tuberculosis Vaccine Treatment Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Tuberculosis Vaccine Treatment Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Tuberculosis Vaccine Treatment Production Market Share 2025
Figure 31. China Based Manufacturers Tuberculosis Vaccine Treatment Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Tuberculosis Vaccine Treatment Production Market Share 2025
Figure 33. World Tuberculosis Vaccine Treatment Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Tuberculosis Vaccine Treatment Production Value Market Share by Type in 2025
Figure 35. Immune Vaccine
Figure 36. Therapy Vaccine
Figure 37. World Tuberculosis Vaccine Treatment Production Market Share by Type (2021-2032)
Figure 38. World Tuberculosis Vaccine Treatment Production Value Market Share by Type (2021-2032)
Figure 39. World Tuberculosis Vaccine Treatment Average Price by Type (2021-2032) & (USD/K Dose)
Figure 40. World Tuberculosis Vaccine Treatment Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 41. World Tuberculosis Vaccine Treatment Production Value Market Share by Application in 2025
Figure 42. Self-Procurement
Figure 43. UNICEF
Figure 44. Other
Figure 45. World Tuberculosis Vaccine Treatment Production Market Share by Application (2021-2032)
Figure 46. World Tuberculosis Vaccine Treatment Production Value Market Share by Application (2021-2032)
Figure 47. World Tuberculosis Vaccine Treatment Average Price by Application (2021-2032) & (USD/K Dose)
Figure 48. Tuberculosis Vaccine Treatment Industry Chain
Figure 49. Tuberculosis Vaccine Treatment Procurement Model
Figure 50. Tuberculosis Vaccine Treatment Sales Model
Figure 51. Tuberculosis Vaccine Treatment Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
